Patents Assigned to Drugmode APS
  • Patent number: 9850458
    Abstract: There is provided a bioreactor which is provided with a lid (13) that facilitates access to the incubation cavity. Specifically the end wall of the incubation cavity is constituted by the lid (13) so that removal of the cap renders the incubation cavity fully accessible.
    Type: Grant
    Filed: December 7, 2011
    Date of Patent: December 26, 2017
    Assignee: DRUGMODE APS
    Inventors: Stephen John Fey, Krzysztof Wrzesinski
  • Patent number: 9574166
    Abstract: A bioreactor or culture vessel for incubation of one or more cell cultures, tissue biopsies, cell clusters, tissue-like structures, “prototissues” or similar samples is described. The bioreactor comprises an incubation chamber, a liquid reservoir and conduction means separated from each other by semipermeable membranes. Specifically, the invention provides a humidity chamber design which simplifies the construction of the bioreactor.
    Type: Grant
    Filed: July 29, 2011
    Date of Patent: February 21, 2017
    Assignee: DRUGMODE APS
    Inventor: Stephen John Fey
  • Publication number: 20130295660
    Abstract: A bioreactor or culture vessel for incubation of one or more cell cultures, tissue biopsies, cell clusters, tissue-like structures, “prototissues” or similar samples. The bioreactor comprises an incubation chamber, a liquid reservoir and conduction means separated from each other by semipermeable membranes. Specifically, the invention provides a humidity chamber design which simplifies the construction of the bioreactor.
    Type: Application
    Filed: July 29, 2011
    Publication date: November 7, 2013
    Applicant: DRUGMODE APS
    Inventor: Stephen John Fey
  • Publication number: 20130260450
    Abstract: There is provided a bioreactor which is provided with a lid (13) that facilitates access to the incubation cavity. Specifically the end wall of the incubation cavity is constituted by the lid (13) so that removal of the cap renders the incubation cavity fully accessible.
    Type: Application
    Filed: December 7, 2011
    Publication date: October 3, 2013
    Applicant: DRUGMODE APS
    Inventors: Stephen John Fey, Krzysztof Wrzesinski
  • Patent number: 7655471
    Abstract: Endometrium secreted polypeptides are assayed in body fluids to determine the presence of polypeptides of specified pI and MW values that have been found to be regulated in body fluids according to the status of the endometrium, or the presence of hyperplasia or adenocarcinoma.
    Type: Grant
    Filed: January 17, 2003
    Date of Patent: February 2, 2010
    Assignee: Drugmode APS
    Inventors: Inger Byrjalsen, Peter M. Larsen, Stephen J. Fey